The natural compound obtusaquinone targets pediatric high-grade gliomas through ROS-mediated ER stress.
Jian TengGhazal LashgariElie I TabetBakhos A TannousPublished in: Neuro-oncology advances (2020)
Our data demonstrate the utility and feasibility of OBT as a potential therapeutic option for improving the clinical treatment of pHGGs.